
NASDAQHealthcareMedical - Care Facilities
最新数据
US$31.10
+US$0.03 · +0.10%
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
前收盘价
US$31.10
+US$0.03 · +0.10%
盘前
US$31.0812
−US$0.0188 · -0.06%
10月13日 7:50 ET
盘中时间采用ET。市场数据可能有所延迟。
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
日内区间
当前US$31.10
52周区间
当前US$31.10
盘中时间采用ET。市场数据可能有所延迟。
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
日内区间
当前US$31.10
52周区间
当前US$31.10
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 56.5亿 USD | 49.98亿 USD | 43.02亿 USD | 39.45亿 USD | 34.39亿 USD |
| 销货成本 | 46.29亿 USD | 39.85亿 USD | 33.21亿 USD | 30.78亿 USD | 26.59亿 USD |
| 毛利 | 10.2亿 USD | 10.13亿 USD | 9.81亿 USD | 8.67亿 USD | 7.8亿 USD |
| 销售、一般及管理费用 | 6.82亿 USD | 6.3亿 USD | 6.07亿 USD | 5.66亿 USD | 5.26亿 USD |
| 营业费用 | 6.82亿 USD | 6.91亿 USD | 6.67亿 USD | 6.27亿 USD | 5.89亿 USD |
| 利息支出 | 6319.6万 USD | 6055.6万 USD | 6222.2万 USD | 5489.6万 USD | 5546.4万 USD |
| 折旧和摊销 | 7069万 USD | 6349.8万 USD | 6220万 USD | 6543.4万 USD | 6880.4万 USD |
| 营业利润 | 3.38亿 USD | 3.22亿 USD | 3.15亿 USD | 2.4亿 USD | 1.91亿 USD |
| 净利润 | 2.08亿 USD | 2.12亿 USD | 2.67亿 USD | 1.51亿 USD | 1.4亿 USD |
公司数据更新于 2026年10月13日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$28.78
下跌空间 7.46%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2020年2月3日 | 1:4 | — | — |
已生效 2020年2月3日
1:4
AI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。